These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16433464)

  • 21. Language pathway abnormalities in schizophrenia: a review of fMRI and other imaging studies.
    Li X; Branch CA; DeLisi LE
    Curr Opin Psychiatry; 2009 Mar; 22(2):131-9. PubMed ID: 19553866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Articulatory rehearsal in verbal working memory: a possible neurocognitive endophenotype that differentiates between schizophrenia and schizoaffective disorder.
    Gruber O; Gruber E; Falkai P
    Neurosci Lett; 2006 Sep; 405(1-2):24-8. PubMed ID: 16875781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early detection and treatment of schizophrenia: how early?
    Riecher-Rössler A; Gschwandtner U; Borgwardt S; Aston J; Pflüger M; Rössler W
    Acta Psychiatr Scand Suppl; 2006; (429):73-80. PubMed ID: 16445487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cognitive remediation and cognitive assistive technologies in schizophrenia].
    Sablier J; Stip E; Franck N
    Encephale; 2009 Apr; 35(2):160-7. PubMed ID: 19393385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Molecular genetics of cognitive deficit in schizophrenia].
    Golimbet VE
    Mol Biol (Mosk); 2008; 42(5):830-9. PubMed ID: 18988532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Schizophrenic disorders--does cognitive dysfunction relate to characteristics of course and psychopathology of the illness?].
    Wciórka J; Bembenek A; Hintze B; Kühn-Dymecka A
    Psychiatr Pol; 2006; 40(5):867-84. PubMed ID: 17217232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How clinical neurophysiology may contribute to the understanding of a psychiatric disease such as schizophrenia.
    Campanella S; Guerit JM
    Neurophysiol Clin; 2009 Feb; 39(1):31-9. PubMed ID: 19268845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurological soft signs and brain morphology in first-episode schizophrenia.
    Thomann PA; Wüstenberg T; Santos VD; Bachmann S; Essig M; Schröder J
    Psychol Med; 2009 Mar; 39(3):371-9. PubMed ID: 18578894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional gray matter volume abnormalities in the at risk mental state.
    Borgwardt SJ; Riecher-Rössler A; Dazzan P; Chitnis X; Aston J; Drewe M; Gschwandtner U; Haller S; Pflüger M; Rechsteiner E; D'Souza M; Stieglitz RD; Radü EW; McGuire PK
    Biol Psychiatry; 2007 May; 61(10):1148-56. PubMed ID: 17098213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Childhood of the schizophrenic patient].
    Da Fonseca D
    Encephale; 2009 Jan; 35 Suppl 1():S2-5. PubMed ID: 19268163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent diffusion tensor imaging findings in early stages of schizophrenia.
    Kyriakopoulos M; Frangou S
    Curr Opin Psychiatry; 2009 Mar; 22(2):168-76. PubMed ID: 19553871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relations among putative biorisk markers in schizotypal adolescents: minor physical anomalies, movement abnormalities, and salivary cortisol.
    Mittal VA; Dhruv S; Tessner KD; Walder DJ; Walker EF
    Biol Psychiatry; 2007 May; 61(10):1179-86. PubMed ID: 17188254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early visual processing deficits in dysbindin-associated schizophrenia.
    Donohoe G; Morris DW; De Sanctis P; Magno E; Montesi JL; Garavan HP; Robertson IH; Javitt DC; Gill M; Corvin AP; Foxe JJ
    Biol Psychiatry; 2008 Mar; 63(5):484-9. PubMed ID: 17945199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between prefrontal brain volume and characteristics of memory strategy in schizophrenia spectrum disorders.
    Matsui M; Suzuki M; Zhou SY; Takahashi T; Kawasaki Y; Yuuki H; Kato K; Kurachi M
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1854-62. PubMed ID: 18796324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early detection and intervention of psychosis. A review.
    Salokangas RK; McGlashan TH
    Nord J Psychiatry; 2008; 62(2):92-105. PubMed ID: 18569772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropsychological impairments in schizophrenia: Integration of performance-based and brain imaging findings.
    Reichenberg A; Harvey PD
    Psychol Bull; 2007 Sep; 133(5):833-58. PubMed ID: 17723032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Schizophrenia and phenotypic plasticity: schizophrenia may represent a predictive, adaptive response to severe environmental adversity that allows both bioenergetic thrift and a defensive behavioral strategy.
    Reser JE
    Med Hypotheses; 2007; 69(2):383-94. PubMed ID: 17321061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis.
    Takahashi T; Wood SJ; Yung AR; Soulsby B; McGorry PD; Suzuki M; Kawasaki Y; Phillips LJ; Velakoulis D; Pantelis C
    Arch Gen Psychiatry; 2009 Apr; 66(4):366-76. PubMed ID: 19349306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics of schizotypal-related obsessive-compulsive disorder.
    Poyurovsky M; Faragian S; Pashinian A; Heidrach L; Fuchs C; Weizman R; Koran L
    Psychiatry Res; 2008 May; 159(1-2):254-8. PubMed ID: 18378321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of brain-derived neurotrophic factor-catecholamine-O-methyltransferase gene interaction on schizophrenic symptoms.
    Han DH; Park DB; Choi TY; Joo SY; Lee MK; Park BR; Nishimura R; Chu CC; Renshaw PF
    Neuroreport; 2008 Jul; 19(11):1155-8. PubMed ID: 18596619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.